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Background: The aim of this study was to describe the results of a 1-year patient follow-up after anterior vaginal
wall darn, a novel technique for the repair of anterior vaginal wall prolapse.
Methods: Fifty-five patients with anterior vaginal wall prolapse underwent anterior vaginal wall darn. The anterior
vaginal wall was detached using sharp and blunt dissection via an incision beginning 1 cm proximal to the external
meatus and extending to the vaginal apex. The space between the tissues that attach the lateral vaginal walls
to the arcus tendineus fasciae pelvis was then darned. Cough Stress Test, Pelvic Organ Prolapse Quantification,
seven-item Incontinence Impact Questionnaire, and six-item Urogenital Distress Inventory scores were performed
1-year postoperatively to evaluate recovery.
Results: One-year postoperatively, all patients were satisfied with the results of the procedure. No patient had
vaginal mucosal erosion or any other complication.
Conclusions: One-year postoperative findings for patients in this series indicate that patients with stage II–III
anterior vaginal wall prolapse were successfully treated with the anterior vaginal wall darn technique.
Keywords: Anterior vaginal wall prolapse, Darn, Pelvic organ prolapse, Stress urinary incontinence,
Surgical techniqueBackground
Pelvic organ prolapse (POP), a condition characterized
by a downward descent of the pelvic organs, causing the
vagina to protrude, afflicts millions of women worldwide
and is increasingly recognized as a global burden on
women’s health [1]. The social, psychological, and eco-
nomical cost of POP can be high [2,3]. During their life-
times, nearly 10% of women will require surgery for
POP, urinary incontinence, or both. Of these, 30% will
undergo two or more surgical procedures, presenting a
challenge to gynaecologist and urologist [4]. The anter-
ior vaginal wall is the segment of the vagina that most
commonly prolapses and is most likely to fail long term
after surgical correction [5]. Central defects have trad-
itionally been treated with anterior colporrhaphy, which* Correspondence: koseonk@yahoo.com.tr
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unless otherwise stated.entails central plication of the fibromuscular layer of the
anterior vaginal wall [6]. Paravaginal defects have been
repaired with vaginal paravaginal repair. Combination
vaginal repair of these defects has been performed with
these two operations [7]. Recurrent anterior vaginal wall
prolapse following conventional repair has been reported
in more than 30% of cases [8].
In an effort to improve outcomes of transvaginal pro-
lapse repair, a number of graft materials have been intro-
duced to complement, reinforce, or replace native tissue
in reconstructive surgical procedures. Although abdom-
inal sacrocolpopexy and suburethral sling procedures, the
standard of care, have been shown to be effective, there is
considerable debate over the use of permanent mesh and
biologic grafts for transvaginal POP repair [9,10].
The use of synthetic graft material for the repair of an-
terior vaginal wall prolapse has been limited by potential
complications related to the mesh, including mesh erosion
and contraction, dyspareunia, pelvic pain and infection. Ad. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Bites were taken from alternate sides of the arcus
tendineus fasciae pelvis using continuous locking 2–0
polypropylene suture, and the tissue edges were slightly
approximated.
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graft-related complications such as graft erosion and in-
fection have caused debate among surgeons regarding the
use of synthetic grafts [11].
For this reason, we introduce a new technique, anter-
ior vaginal wall darn (AVWD) which is carried out with-
out mesh. Unlike colporrhaphy, this technique does not
cause tissue tension and is easy to perform, and in con-
trast to the use of mesh, it does not corrupt the anatom-
ical structures.
Methods
Fifty-five patients who had been experiencing POP
symptoms for the previous 9 months and stage II–III
prolapse of the anterior vaginal wall were enrolled be-
tween September 2011 and July 2012. Patients provided
written informed consent to participate, and the study
protocol had been approved by the Ethics Committee of
Sakarya University Medical Faculty.
Preoperative evaluation consisted of complete medical
history, gynaecological examination, cough stress test
(CST), voiding diary, daily pad use, Q-tip test, and
seven-item Incontinence Impact Questionnaire (IIQ-7)
and six-item Urogenital Distress Inventory (UDI-6)
scores. Patients’ symptoms were also evaluated via
standard questions asked by the examining physician.
The severity of prolapse was assessed using the POP
Quantification (POPQ) system adopted by the Inter-
national Continence Society. Daily pad weight was used
to quantify patients’ subjective complaints.
Exclusion criteria were a history of pelvic or vaginal
surgery, predominant urge incontinence, pelvic or sys-
temic infection, inguinal or vulvar abscess, pregnancy,
urinary tract obstruction or renal insufficiency, pelvic
pain unrelated to prolapse, vaginal bleeding of unknown
aetiology, blood coagulation disorders, pelvic malignancy
or previous irradiation of the pelvic region, vaginal ero-
sion or severe vaginal atrophy, vaginal or urethral fistula,
and known allergy to the suture material. Patients re-
quiring concomitant vaginal vault suspension, such as
sacrospinous ligament fixation; sacrocolpopexy for vagi-
nal prolapse or uterine procidentia; or laparotomy or
laparoscopy for any reason, were also excluded.
All AVWD procedures were performed by the same
surgeon as follows: after insertion of an 18-Fr indwelling
urethral catheter, an adequate volume of normal saline
was injected under the vaginal mucosa to provide com-
fortable dissection in an accurate plane with limited
haemorrhage. A midline incision was made beginning
1 cm proximal to the external urethral meatus and ex-
tending to the vaginal apex. The anterior vaginal wall
was detached from the urinary bladder beyond the an-
terior vaginal sulcus using sharp and blunt dissection
until the arcus tendinous fasciae pelvis (ATFP) wasexposed. Using a continuous locking 2–0 polypropylene
suture, bites were taken on alternate sides from distal to
proximal in the ATFP and the tissues that attach the lat-
eral walls of the vagina to the ATFP (Figure 1). After
6 cm, at the point where the ATFP exits the anterior vagi-
nal wall, the sutures were placed medial to the perivesical
fascia for 2–3 cm. The running sutures were turned back
from the cardinal ligaments without being tied and were
extended continuously to the distal aspect to form a
darn. The suture ends were tied together (Figures 2
and 3). The traumatized vaginal mucosa was trimmed and
closed with a continuous absorbable sutures, and a vaginal
pack soaked in antibiotic solution was inserted.
Postoperative evaluation, including POPQ measure-
ment, UDI-6, and IIQ-7 scores, was performed for each
patient, 1 year after the AVWD procedure. A Q-tip test
was performed to evaluate urethral hypermobility. Pre-
and postoperative questionnaire scores and POPQ mea-
surements were analyzed using Wilcoxon signed rank
test. SPSS for Windows, Version 12.0 (SPSS, Inc., Chi-
cago, IL, USA) was used for data analysis. The level of
statistical significance was set at P < 0.05.
Results
Fifty-five patients with anterior POP stage II–III were
eligible to participate in the study. The patients age range
was 35–67 years (median age 51 years). Baseline demo-
graphic and clinical parameters are shown in Table 1. Me-
dian surgical duration was 40 minutes (range: 30–45 min),
mean duration of hospitalization was 1.7 days (range: 1–2
Figure 2 The suture was extended continuously to the distal
aspect to form a darn.
Figure 3 Surgical view of the ends of the suture. (Consent was
obtained from the patient to publish this image. A copy of the
written consent is available for review by the Editor of this journal).
Table 1 Patient characteristics at baseline
Characteristic n = 55 (%)
Age 51 ± 16.3
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1–2 days). Pre- and postoperative POPQ measurements,
shown in Table 2, reveal significant improvements at
points Aa and Ba. Similarly, UDI-6 and IIQ-7 scores were
significantly lower postoperatively (P < 0.001) (Table 2).
Similarly, UDI-6 and IIQ-7 scores were significantly lower
postoperatively (p < 0.001) (Table 2).
Moderate groin discomfort was the most common
complaint immediately postoperatively but disappeared
within 10 days of analgesic therapy. One-year postopera-
tively, all patients underwent a complete evaluation. Symp-
tom relief 12 months post-surgery is shown at Table 3.
Upon examination, CST was negative in 90.9% of patients
and vaginal examination were appeared normal in all pa-
tients. Bladder ultrasonography demonstrated no signifi-
cant post-void residual urine volume.
Discussion
The goal of treatment of POP is to improve patient qual-
ity of life rather than prolong survival; therefore, when
choosing a surgical method for anterior vaginal wall pro-
lapse, it is important to consider all possible complications
as well as treatment outcome [12]. Although conservative
treatment is a reasonable initial approach for urinary in-
continence, surgical management is usually required for
symptomatic grade II-III vaginal prolapse. Many surgical
methods are currently known, but unfortunately none can
solve the problems caused by POP.
There is a lack of consensus concerning when, where,
and how to perform surgery, preferably as a single proced-
ure, to provide the best outcome in patients with POP.
When selecting a surgical procedure for POP, pertinent
factors, including history of anti-incontinence surgery,
sexual activity, coital incontinence, obesity, chronic in-
creases in intra-abdominal pressure, mixed incontinence
and concurrent overactive bladder must be considered.
In an effort to improve the outcomes of transvaginal
prolapse repair, a number of biologic and synthetic graft
Table 2 POPQ and incontinence-related quality values
Before operation After operation P value
POPQ measurements Aa (cm) 1.6 ± 1.0 −2.1 ± 0.7 <0.001
POPQ measurements Ba (cm) 2.3 ± 1.5 −2.0 ± 0.8 <0.001
POPQ measurements Ap (cm) −2.2 ± 0.6 −2 ± 0.7 0.17
POPQ measurements Bp (cm) −2.78 ± 0.4 −2.61 ± 0.52 0.18
POPQ measurements TVL (cm) 7.62-0.51- 7.13-0.62 0.53
POPQ measurements C (cm) −5.5 ± 1.4 −6.3 ± 1.2 0.046
UDI-6 8.9 ± 3.7 1.6 ± 1.2 <0.001
IIQ-7 10.5 ± 5.3 0.9 ± 0.8 <0.001
Q-TT 28.7 ± 6.2 15.3 ± 10.4 <0.018
Pad count (d) 4.3 ± 1.6 0.4 ± 0.9 <0.001
Residual urine volume (ml) 58.1 ± 13.2 32.2 ± 10.6 0.024
IIQ-7, seven-item Incontinence Impact Questionnaire; POPQ, Pelvic Organ Prolapse Quantification; Q-TT, Q-Tip test; UDI-6, six-item Urogenital Distress Inventory.
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reconstructive surgical procedures to reinforce or replace
native tissue [13]. Results have been favourable, with ana-
tomical success rates in the range of 59% to 94%; however,
the use of mesh in vaginal repair procedures remains
controversial [9,14-16]. Recently, significant problems
associated with mesh use in vaginal prolapse surgery
(dyspareunia, vaginal pain, mesh shrinkage, bladder ero-
sion, fistula, mesh exposure and infection) have been re-
ported [17-21]. Vaginal mesh erosion is one of the most
common complications of introducing synthetic mater-
ial via the vaginal route. Differences in mesh types,
follow-up periods, and definitions of success and failure
have contributed to inconsistent reported erosion rates.
No generally accepted “safety time zone” for mesh ex-
posure or erosion has been accepted, and the complica-
tion can occur many years after mesh placement. Young
age and sexual activity are additional risk factors for
mesh exposure [22].
Although there is increasing industry pressure on sur-
geons to adopt mesh-augmented repairs into their prac-
tice and many surgeons are employing the therapy
liberally, health organizations such as the US Food and
Drug Administration warn urogynaecologists and pa-
tients about the dangers of using mesh materials for theTable 3 Postoperative symptom relief
Preoperative Postoperative
Pelvic pressure 33 4
Sensation of a mass
bulging into the vagina
43 1
Stress urinary incontinence 16 2
Coital incontinence 11 1
Difficulties in emptying the bladder 10 1
Mixed urinary incontinence 13 3
Dyspareunia 12 3treatment of POP [23,24]. The committee for POP at
the 3rd International Consultation on Incontinence con-
cluded that there were insufficient data to reach a defini-
tive conclusion regarding the role of biologic or
synthetic prosthetic materials in surgical procedures for
primary or recurrent prolapse [25].
The available data concerning the results of prolapse
surgery remain mixed. Success rate varies substantially
depending on the technique used. Despite high anatom-
ical recurrence rates, traditional anterior colporrhaphy,
and paravaginal repair have been used for years for the
treatment of combined anterior vaginal wall prolapse
[26,27]. However, although pubocervical fascia is used to
place plication sutures during anterior colporrhaphy,
histologic examination of the anterior vaginal wall has
failed to show a separate layer of fascia between the va-
gina and bladder [28], and paravaginal repair has been
used only for paravaginal defects.
The tissue into which darn suture is placed during the
novel AVWD procedure described herein is the ATFP,
or white line, a fibrous thickening that consists of par-
ietal fascia from the surrounding pubococcygeus and
iliococcygeus portions of the levator ani and the obtur-
ator internus muscles [6]. The ATFP is important in
providing support to pelvic structures. Cadaveric studies
have shown that the anterior segment of the ATFP is at-
tached to the lower posterior side of the body of the
pubic bone, approximately 1 cm from the pubic symphy-
sis; that the first 6 cm is attached anteriorly to the an-
terolateral vagina, creating the anteriorlateral vaginal
sulci; and that it is also attached to the ischial spines and
gets some fibres from adjacent fascias [29]. Detachment
of this lateral support is the primary cause of paravaginal
defects and can lead to prolapse of the anterior vaginal
wall [30]. Although it may be injured during pregnancy,
the ATFP is a point of attachment for many gynaecolo-
gic procedures.
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with a high risk of recurrence. Failed tissue repair is most
often due to the apposition and suturing together under
tension of structures in positions other than normal ana-
tomic, as occurs in traditional anterior colporrhaphy. The
principle behind AVWD for the repair of prolapse is simi-
lar to that of the nylon darn method, which was com-
monly used for the treatment of inguinal hernia before the
advent of mesh and is still used by some general surgeons
instead of mesh repair [31]. The rational for the darn pro-
cedure is that it forms a meshwork of non-absorbable su-
tures that is well tolerated by the tissues and fills the
interstices with fibrous connective tissue, providing a but-
tress across the weakened area of the anterior vaginal wall.
This technique is therefore a compensatory repair that fa-
cilitates the repair of anterior vaginal wall prolapse with-
out distorting the normal anatomy and without creating
suture-line tension, which can be used for central, lateral
and combined defects. The procedure is in harmony with
the anatomical structures and creates a hammock that re-
inforces the native support tissue, does not cause tension
and confers very a low risk of vaginal mucosal erosion and
urinary bladder injury.
The AVWD procedure also creates support under the
bladder neck, and can therefore help to alleviate urethral
hypermobility. Our postoperative 1-year Q-tip test re-
sults showed that average urethral angle dropped from
28.7 ± 6.2 degrees to 15.3 ± 10.4 degrees (p < 0.018). CST
was negative in 90.9% of patients. We attribute this re-
sults to darn sutures passing under the bladder neck.
Conclusions
In the present initial series, early postoperative findings
indicate that stage II-III anterior POP was successfully
treated with the AVWD technique and that the compli-
cation rate was low; however, based on the early postop-
erative appearance of the anatomic site, AVWD does not
appear to be as good as the mesh technique. Neverthe-
less, AVWD can be easily performed in patients who are
concerned about serious adverse effects seen with mesh,
such as erosion, mesh shrinkage, bladder erosion, fistula,
mesh exposure and infection.
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